Optical Prism April 2016 | Page 32

COLLEGE OF OPTOMETRISTS RECOMMENDING CHANGES TO DRUG REGULATIONS By Denis Langlois Ontario's college of optometrists wants Certain safeguards are recommended, its members to have the freedom to pre- such as requiring optometrists to im- scribe to their patients any ophthalmic mediately refer patients to a physician drug approved by Health Canada. or hospital once they are prescribed The self-regulatory authority is propos- certain categories of oral drugs. ing amendments to the Optometry Act Wilkinson said the college often hears that it says would knock down a barrier from its members about how the current that prevents optometrists from access- drug list inconveniences their patients ing newer drugs, which can often be the or limits the care they can receive. best treatment option for patients. As an example, the anti-glaucoma drug “If the new proposal is passed, patients Azarga was approved by Health Canada will have access to the most up-to-date in 2009; too late for it to be recommend- therapies without the need for regula- ed for the original list, Wilkinson said. tion change,” said David Wilkinson, The drug is a combination of brinzola- practice advisor for the College of mide and timolol, which are both Optometrists of Ontario. included separately on the list. Since 2011, optometrists have been “Right now, if an optometrist concludes authorized to prescribe certain drugs that a patient with primary open-angle for treating eye and vision system glaucoma can benefit from this combi- conditions in their patients. nation therapy, he/she must make a Those drugs are listed in Schedule 1 of decision. Either prescribe both drugs the Optometry Act's designated drugs and standards of practice regulation. Wilkinson said the list has not been amended since it came into effect five years ago. The college says its experience has demonstrated that such lists separately (two separate drops for the patient), or refer the patient to an ophthalmologist, who can then prescribe Azarga (one drop for the patient). In general, there are convenience and compliance advantages when fewer in regulations are difficult to revise. drops are required,” Wilkinson said. The college is proposing to amend the “There are numerous other examples regulation by scrapping the list and instead giving optometrists the authority where the best therapy for a condition may no longer be a drug that is on the to prescribe all oral and topical drugs current list.” within the scope of practice of optometry. The college says its recommended “This (would) expand the range of amendment would bring Ontario in treatment options available to patients, some of whom might benefit from older drugs and some from newer. What we’re aiming for is the best treatment possible,” Wilkinson said. 30 Optical Prism | April 2016 line with recent changes in Alberta and Saskatchewan and most American states. The college had requested feedback on its proposal by March 28. Wilkinson said it will now review all comments received. The committee responsible for the proposal will then ask the college council to either amend the recommendation and re-circulate it to members and stakeholders or submit the current proposal to the Ministry of Health and Long-Term Care to seek their approval. Wilkinson said the college expects it will submit its final proposal later this year. Along with the recommended change to the drug list regulation, the college is also proposing to amend the Optometry Act to allow optometrists to remove superficial foreign bodies from a patient's cornea and to dispense drugs for the sole purpose of trialling a therapy. The college also wants the act amended to specify diagnostic ultrasound as a prescribed form of energy for the performance of corneal pachymetry or ocular ultrasonography, only. More information on the college's proposals can be found online at www.collegeoptom.on.ca.